Tuesday, February 16, 2010

Letter RE: "A First: Diagnosis by DNA" --Forbes Magazine

Mr. Herper's March 15th article suggests that the FDA regulate genomic sequencing technology. But, in addition to helping physicians like Dr. Lifton make diagnoses, sequencing technology is an important component of  modern scientific research.  By regulating the use of genomic diagnosis at its source, the FDA will serve only to substantially impede basic science research and the vast informational resources it promises to bring. The use of sequencing technology is already gaining significant commercial traction - perhaps the FTC is a better agency to provide consumer protection from misuse of the technology.

Dov Greenbaum
Mark Gerstein

Unpublished Letter in Response to:
A First: Diagnosis By DNA
By: Matthew Herper
February 14, 2010
Forbes Magazine

No comments:

Post a Comment